You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
春立醫療(01858.HK)獲Syntellix Asia授出獨家權利於中國分銷合同產品
格隆匯 10-31 22:35

格隆匯10月31日丨春立醫療(01858.HK)宣佈,公司與Syntellix Asia訂立一份合作和分銷協議,據此,Syntellix Asia向公司授出獨家權利於中國分銷合同產品。公司將負責取得監管批文以及於中國營銷、推廣及銷售合同產品。根據合作和分銷協議,公司須於五年期內採購特定最低購買量的合同產品。倘公司未能達到五年最低購買量承諾,則Syntellix Asia有權終止合作和分銷協議。

合作和分銷協議的有效期至2024年12月31日為止(除非被提前終止),且根據合作和分銷協議最多可延長5年。

Syntellix Asia為一家於2015年在新加坡註冊成立的私人有限公司。該公司專門從事研發、營銷及銷售高度創新的可轉換金屬植入物。

集團預期將受惠於作為獨家分銷商在中國分銷合同產品而產生的營業收入的增加。因此,董事會認為訂立合作和分銷協議為集團進一步擴展其業務及營業收入基礎的良機。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account